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Escherichia coli is one of the organisms of choice for the production of recombinant
proteins. Its use as a cell factory is well-established and it has become the most popular
expression platform. For this reason, there are many molecular tools and protocols at hand
for the high-level production of heterologous proteins, such as a vast catalog of expression
plasmids, a great number of engineered strains and many cultivation strategies.We review
the different approaches for the synthesis of recombinant proteins in E. coli and discuss
recent progress in this ever-growing ﬁeld.
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INTRODUCTION
There is no doubt that the production of recombinant proteins
in microbial systems has revolutionized biochemistry. The days
where kilograms of animal and plant tissues or large volumes
of biological ﬂuids were needed for the puriﬁcation of small
amounts of a given protein are almost gone. Every researcher
that embarks on a new project that will need a puriﬁed protein
immediately thinks of how to obtain it in a recombinant form.
The ability to express and purify the desired recombinant protein
in a large quantity allows for its biochemical characterization, its
use in industrial processes and the development of commercial
goods.
At the theoretical level, the steps needed for obtaining a recom-
binant protein are pretty straightforward. You take your gene of
interest, clone it in whatever expression vector you have at your
disposal, transform it into the host of choice, induce and then, the
protein is ready for puriﬁcation and characterization. In practice,
however, dozens of things can go wrong. Poor growth of the host,
inclusion body (IB) formation, protein inactivity, and even not
obtaining any protein at all are some of the problems often found
down the pipeline.
In the past, many reviews have covered this topic with great
detail (Makrides, 1996; Baneyx, 1999; Stevens, 2000; Jana and
Deb, 2005; Sorensen and Mortensen, 2005). Collectively, these
papers gathermore than 2000 citations. Yet, in theﬁeld of recombi-
nant protein expression and puriﬁcation, progress is continuously
being made. For this reason, in this review, we comment on
the most recent advances in the topic. But also, for those with
modest experience in the production of heterologous proteins,
we describe the many options and approaches that have been
successful for expressing a great number of proteins over the
last couple of decades, by answering the questions needed to be
addressed at the beginning of the project. Finally, we provide a
troubleshooting guide that will come in handy when dealing with
difﬁcult-to-express proteins.
FIRST QUESTION: WHICH ORGANISM TO USE?
The choice of the host cell whose protein synthesis machinery
will produce the precious protein will initiate the outline of the
whole process. It deﬁnes the technology needed for the project,
be it a variety of molecular tools, equipment, or reagents. Among
microorganisms, host systems that are available include bacteria,
yeast, ﬁlamentous fungi, and unicellular algae. All have strengths
and weaknesses and their choice may be subject to the protein of
interest (Demain and Vaishnav, 2009; Adrio and Demain, 2010).
For example, if eukaryotic post-translational modiﬁcations (like
protein glycosylation) are needed, a prokaryotic expression sys-
tem may not be suitable (Sahdev et al., 2008). In this review,
we will focus speciﬁcally on Escherichia coli. Other systems are
described in excellent detail in accompanying articles of this
series.
The advantages of using E. coli as the host organism are well
known. (i) It has unparalleled fast growth kinetics. In glucose-salts
media and given the optimal environmental conditions, its dou-
bling time is about 20 min (Sezonov et al., 2007). This means that
a culture inoculated with a 1/100 dilution of a saturated starter
culture may reach stationary phase in a few hours. However, it
should be noted that the expression of a recombinant protein
may impart a metabolic burden on the microorganism, causing
a considerable decrease in generation time (Bentley et al., 1990).
(ii) High cell density cultures are easily achieved. The theoretical
density limit of an E. coli liquid culture is estimated to be about
200 g dry cell weight/l or roughly 1 × 1013 viable bacteria/ml (Lee,
1996; Shiloach and Fass, 2005). However, exponential growth in
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complex media leads to densities nowhere near that number. In
the simplest laboratory setup (i.e., batch cultivation of E. coli at
37◦C, using LB media), <1 × 1010 cells/ml may be the upper
limit (Sezonov et al., 2007), which is less than 0.1% of the theoret-
ical limit. For this reason, high cell-density culture methods were
designed to boost E. coli growth, even when producing a recom-
binant protein (Choi et al., 2006). Being a workhorse organism,
these strategies arose thanks to the wealth of knowledge about
its physiology. (iii) Rich complex media can be made from read-
ily available and inexpensive components. (iv) Transformation
with exogenous DNA is fast and easy. Plasmid transformation of
E. coli can be performed in as little as 5 min (Pope and Kent,
1996).
SECOND QUESTION: WHICH PLASMID SHOULD BE CHOSEN?
The most common expression plasmids in use today are the
result of multiple combinations of replicons, promoters, selec-
tion markers, multiple cloning sites, and fusion protein/fusion
protein removal strategies (Figure 1). For this reason, the catalog
of available expression vectors is huge and it is easy to get lost when
choosing a suitable one. To make an informed decision, these fea-
tures have to be carefully evaluated according to the individual
needs.
REPLICON
Genetic elements that undergo replication as autonomous units,
such as plasmids, contain a replicon. It consists of one origin of
replication together with its associated cis-acting control elements.
An important parameter to have in mind when choosing a suitable
vector is copy number. The control of copy number resides in the
replicon (del Solar and Espinosa, 2000). It is logical to think that
high plasmid dosage equals more recombinant protein yield as
many expression units reside in the cell. However, a high plasmid
number may impose a metabolic burden that decreases the bacte-
rial growth rate and may produce plasmid instability, and so the
number of healthy organisms for protein synthesis falls (Bentley
et al., 1990; Birnbaum and Bailey, 1991). For this reason, the use
of high copy number plasmids for protein expression by no means
implies an increase in production yields.
Commonly used vectors, such as the pET series, possess the
pMB1 origin (ColE1-derivative, 15–60 copies per cell; Bolivar
et al., 1977) while a mutated version of the pMB1 origin is present
in the pUC series (500–700 copies per cell; Minton, 1984). The
wild-type ColE1 origin (15–20 copies per cell; Lin-Chao and
Bremer, 1986; Lee et al., 2006) can be found in the pQE vec-
tors (Qiagen). They all belong to the same incompatibility group
meaning that they cannot be propagated together in the same cell
as they compete with each other for the replication machinery
(del Solar et al., 1998; Camps, 2010). For the dual expression of
recombinant proteins using two plasmids, systems with the p15A
ori are available (pACYC and pBAD series of plasmids, 10–12
copies per cell; Chang and Cohen, 1978; Guzman et al., 1995).
Though rare, triple expression can be achieved by the use of the
pSC101 plasmid. This plasmid is under a stringent control of repli-
cation, thus it is present in a low copy number (<5 copies per
cell; Nordstrom, 2006). The use of plasmids bearing this repli-
con can be an advantage in cases where the presence of a high
dose of a cloned gene or its product produces a deleterious effect
to the cell (Stoker et al., 1982; Wang and Kushner, 1991). Alter-
natively, the use of the Duet vectors (Novagen) simpliﬁes dual
expression by allowing cloning of two genes in the same plas-
mid. The Duet plasmids possess two multiple cloning sites, each
preceded by a T7 promoter, a lac operator and a ribosome bind-
ing site. By combining different compatible Duet vectors, up to
eight recombinant proteins can be produced from four expression
plasmids.
FIGURE 1 | Anatomy of an expression vector.The figure depicts the major features present in common expression vectors. All of them are described in
the text. The afﬁnity tags and coding sequences for their removal were positioned arbitrarily at the N-terminus for simplicity. MCS, multiple cloning site. Striped
patterned box: coding sequence for the desired protein.
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PROMOTER
The staple in prokaryotic promoter research is undoubtedly the
lac promoter, key component of the lac operon (Müller-Hill,
1996). The accumulated knowledge in the functioning of the
system allowed for its extended use in expression vectors. Lac-
tose causes induction of the system and this sugar can be used
for protein production. However, induction is difﬁcult in the
presence of readily metabolizable carbon sources (such as glu-
cose present in rich media). If lactose and glucose are present,
expression from the lac promoter is not fully induced until all
the glucose has been utilized. At this point (low glucose), cyclic
adenosine monophosphate (cAMP) is produced, which is neces-
sary for complete activation of the lac operon (Wanner et al., 1978;
Postma and Lengeler, 1985). This positive control of expression is
known as catabolite repression. In accordance, cAMP levels are
low in cells growing in lac operon-repressing sugars, and this cor-
relates with lower rates of expression of the lac operon (Epstein
et al., 1975). Also, glucose abolishes lactose uptake because lac-
tose permease is inactive in the presence of glucose (Winkler
and Wilson, 1967). To achieve expression in the presence of glu-
cose, a mutant that reduces (but does not eliminate) sensitivity to
catabolite regulation was introduced, the lacUV5 promoter (Sil-
verstone et al., 1970; Lanzer and Bujard, 1988). However, when
present in multicopy plasmids, both promoters suffer from the
disadvantage of sometimes having unacceptably high levels of
expression in the absence of inducer (a.k.a. “leakiness”) due to
titration of the low levels of the lac promoter repressor pro-
tein LacI from the single chromosomal copy of its gene (about
10 molecules per cell; Müller-Hill et al., 1968). Basal expression
control can be achieved by the introduction of a mutated pro-
moter of the lacI gene, called lacIQ, that leads to higher levels of
expression (almost 10-fold) of LacI (Calos, 1978). The lac pro-
moter and its derivative lacUV5 are rather weak and thus not
very useful for recombinant protein production (Deuschle et al.,
1986; Makoff and Oxer, 1991). Synthetic hybrids that combine the
strength of other promoters and the advantages of the lac pro-
moter are available. For example, the tac promoter consists of
the −35 region of the trp (tryptophan) promoter and the −10
region of the lac promoter. This promoter is approximately 10
times stronger than lacUV5 (de Boer et al., 1983). Notable exam-
ples of commercial plasmids that use the lac or tac promoters to
drive protein expression are the pUC series (lacUV5 promoter,
Thermo Scientiﬁc) and the pMAL series of vectors (tac promoter,
NEB).
The T7 promoter system present in the pET vectors (pMB1
ori, medium copy number, Novagen) is extremely popular for
recombinant protein expression. This is not surprising as the
target protein can represent 50% of the total cell protein in suc-
cessful cases (Baneyx, 1999; Graumann and Premstaller, 2006).
In this system, the gene of interest is cloned behind a promoter
recognized by the phage T7 RNA polymerase (T7 RNAP). This
highly active polymerase should be provided in another plas-
mid or, most commonly, it is placed in the bacterial genome
in a prophage (λDE3) encoding for the T7 RNAP under the
transcriptional control of a lacUV5 promoter (Studier and Mof-
fatt, 1986). Thus, the system can be induced by lactose or its
non-hydrolyzable analog isopropyl β-D-1-thiogalactopyranoside
(IPTG). Basal expression can be controlled by lacIQ but also by T7
lysozyme co-expression (Moffatt and Studier, 1987). T7 lysozyme
binds to T7 RNAP and inhibits transcription initiation from the
T7 promoter (Stano and Patel, 2004). In this way, if small amounts
of T7 RNAP are produced because of leaky expression of its gene,
T7 lysozyme will effectively control unintended expression of het-
erologous genes placed under the T7 promoter. T7 lysozyme is
provided by a compatible plasmid (pLysS or pLysE). After induc-
tion, the amount of T7 RNAP produced surpasses the level of
polymerase that T7 lysozyme can inhibit. The “free” T7 RNAP
can thus engage in transcription of the recombinant gene. Yet
another level of control lies in the insertion of a lacO operator
downstream of the T7 promoter, making a hybrid T7/lac pro-
moter (Dubendorff and Studier, 1991). All three mechanisms
(tight repression of the lac-inducible T7 RNAP gene by lacIQ, T7
RNAP inhibition by T7 lysozyme and presence of a lacO operator
after the T7 promoter) make the system ideal for avoiding basal
expression.
The problem of leaky expression is a reﬂection of the nega-
tive control of the lac promoter. Promoters that rely on positive
control should have lower background expression levels (Siegele
and Hu, 1997). This is the case of the araPBAD promoter present
in the pBAD vectors (Guzman et al., 1995). The AraC protein
has the dual role of repressor/activator. In the absence of ara-
binose inducer, AraC represses translation by binding to two
sites in the bacterial DNA. The protein–DNA complex forms a
loop, effectively preventing RNA polymerase from binding to the
promoter. Upon addition of the inducer, AraC switches into “acti-
vation mode” and promotes transcription from the ara promoter
(Schleif, 2000,2010). In thisway, arabinose is absolutely needed for
induction.
Another widely used approach is to place a gene under the
control of a regulated phage promoter. The strong leftward pro-
moter (pL) of phage lambda directs expression of early lytic
genes (Dodd et al., 2005). The promoter is tightly repressed by
the λcI repressor protein, which sits on the operator sequences
during lysogenic growth. When the host SOS response is trig-
gered by DNA damage, the expression of the protein RecA is
stimulated, which in turn catalyzes the self-cleavage of λcI, allow-
ing transcription of pL-controlled genes (Johnson et al., 1981;
Galkin et al., 2009). This mechanism is used in expression vectors
containing the pL promoter. The SOS response (and recom-
binant protein expression) can be elicited by adding nalidixic
acid, a DNA gyrase inhibitor (Lewin et al., 1989; Shatzman
et al., 2001). Another way of activating the promoter is to con-
trol λcI production by placing its gene under the inﬂuence of
another promoter. This two-stage control system has already
been described for T7 promoter/T7 RNAP-based vectors. In the
pLEX series of vectors (Life Technologies), the λcI repressor gene
was integrated into the bacterial chromosome under the control
of the trp promoter. In the absence of tryptophan, this pro-
moter is always “on” and λcI is continuously produced. Upon
addition of tryptophan, a tryptophan-TrpR repressor complex
is formed that tightly binds to the trp operator, thereby block-
ing λcI repressor synthesis. Subsequently, the expression of the
desired gene under the pL promoter ensues (Mieschendahl et al.,
1986).
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Transcription from all promoters discussed so far is initiated
by chemical cues. Systems that respond to physical signals (e.g.,
temperature or pH) are also available (Goldstein and Doi, 1995).
The pL promoter is one example. A mutant λcI repressor protein
( λcI857) is temperature-sensitive and is unstable at temperatures
higher than 37◦C. E. coli host strains containing the λcI857 pro-
tein (either integrated in the chromosome or into a vector) are
ﬁrst grown at 28–30◦C to the desired density, and then protein
expression is induced by a temperature shift to 40–42◦C (Menart
et al., 2003; Valdez-Cruz et al., 2010). The industrial advantage
of this system lies in part in the fact that during fermenta-
tion, heat is usually produced and increasing the temperature in
high density cultures is easy. On the other hand, genes under
the control of the cold-inducible promoter cspA are induced by
a downshift in temperature to 15◦C (Vasina et al., 1998). This
temperature is ideal for expressing difﬁcult proteins as will be
explained in another section. The pCold series of plasmids have
a pUC118 backbone (a pUC18 derivative; Vieira and Messing,
1987) with the cspA promoter (Qing et al., 2004; Hayashi and
Kojima, 2008). In the original paper, successful expression was
achieved for more than 30 recombinant proteins from different
sources, reaching levels as high as 20–40% of the total expressed
proteins (Qing et al., 2004). However, it should be noted that in
various cases the target proteins were obtained in an insoluble
form.
SELECTION MARKER
To deter the growth of plasmid-free cells, a resistance marker is
added to the plasmid backbone. In the E. coli system, antibiotic
resistance genes are habitually used for this purpose. Resistance
to ampicillin is conferred by the bla gene whose product is a
periplasmic enzyme that inactivates the β-lactam ring of β-lactam
antibiotics. However, as the β-lactamase is continuously secreted,
degradation of the antibiotic ensues and in a couple of hours,
ampicillin is almost depleted (Korpimaki et al., 2003). Under this
situation, cells not carrying the plasmid are allowed to increase in
number during cultivation. Although not experimentally veriﬁed,
selective agents in which resistance is based on degradation, like
chloramphenicol (Shaw, 1983) and kanamycin (Umezawa, 1979),
could also have this problem. For this reason, tetracycline has been
shown to be highly stable during cultivation (Korpimaki et al.,
2003), because resistance is based on active efﬂux of the antibiotic
from resistant cells (Roberts, 1996).
The cost of antibiotics and the dissemination of antibiotic
resistance are major concerns in projects dealing with large-
scale cultures. Much effort has been put in the development of
antibiotics-free plasmid systems. These systems are based on the
concept of plasmid addiction, a phenomenon that occurs when
plasmid-free cells are not able to grow or live (Zielenkiewicz and
Ceglowski, 2001; Peubez et al., 2010). For example, an essen-
tial gene can be deleted from the bacterial genome and then
placed on a plasmid. Thus, after cell division, plasmid-free bac-
teria die. Different subtypes of plasmid-addiction systems exist
according to their principle of function: (i) toxin/antitoxin-
based systems, (ii) metabolism-based systems, and (iii) oper-
ator repressor titration systems (Kroll et al., 2010). While this
promising technology has been proved successful in large-scale
fermentors (Voss and Steinbuchel, 2006; Peubez et al., 2010),
expression systems based on plasmid addiction are still not widely
distributed.
AFFINITY TAGS
When devising a project where a puriﬁed soluble active recom-
binant protein is needed (as is often the case), it is invaluable
to have means to (i) detect it along the expression and puriﬁca-
tion scheme, (ii) attain maximal solubility, and (iii) easily purify
it from the E. coli cellular milieu. The expression of a stretch of
amino acids (peptide tag) or a large polypeptide (fusion partner)
in tandem with the desired protein to form a chimeric protein may
allow these three goals to be straightforwardly reached (Nilsson
et al., 1997).
Being small, peptide tags are less likely to interfere when fused
to the protein. However, in some cases they may provoke nega-
tive effects on the tertiary structure or biological activity of the
fused chimeric protein (Bucher et al., 2002; Klose et al., 2004;
Chant et al., 2005; Khan et al., 2012). Vectors are available that
allow positioning of the tag on either the N-terminal or the
C-terminal end (the latter option being advantageous when a
signal peptide is positioned at the N-terminal end for secretion
of the recombinant protein, see below). If the three-dimensional
structure of the desired protein is available, it is wise to check
which end is buried inside the fold and place the tag in the
solvent-accessible end. Common examples of small peptide tags
are the poly-Arg-, FLAG-, poly-His-, c-Myc-, S-, and Strep II-
tags (Terpe, 2003). Since commercial antibodies are available for
all of them, the tagged recombinant protein can be detected by
Western blot along expression trials, which is extremely helpful
when the levels of the desired proteins are not high enough to
be detected by SDS-PAGE. Also, tags allow for one-step afﬁnity
puriﬁcation, as resins that tightly and speciﬁcally bind the tags
are available. For example, His-tagged proteins can be recovered
by immobilized metal ion afﬁnity chromatography using Ni2+
or Co2+-loaded nitrilotriacetic acid-agarose resins (Porath and
Olin, 1983; Bornhorst and Falke, 2000), while anti-FLAG afﬁnity
gels (Sigma-Aldrich) are used for capturing FLAG fusion proteins
(Hopp et al., 1988).
On the other hand, adding a non-peptide fusion partner
has the extra advantage of working as solubility enhancers
(Hammarstrom et al., 2002). The most popular fusion tags are
the maltose-binding protein (MBP; Kapust and Waugh, 1999),
N-utilization substance protein A (NusA; Davis et al., 1999),
thioredoxin (Trx; LaVallie et al., 1993), glutathione S-transferase
(GST; Smith and Johnson, 1988), ubiquitin (Baker, 1996) and
SUMO (Butt et al., 2005). The reasons why these fusion partners
act as solubility enhancers remain unclear and several hypothe-
sis have been proposed (reviewed in Raran-Kurussi and Waugh,
2012). In the case of MBP, it was shown that it possesses an
intrinsic chaperone activity (Kapust and Waugh, 1999; Raran-
Kurussi and Waugh, 2012). In comparison studies, GST showed
the poorest solubility enhancement capabilities (Hammarstrom
et al., 2006; Bird, 2011). NusA, MBP, and Trx display the best
solubility enhancing properties but their large size may lead to
the erroneous assessment of protein solubility (Costa et al., 2013).
Indeed, when these tags are removed, the ﬁnal solubility of the
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desired product is unpredictable (Esposito and Chatterjee, 2006).
For these reasons, smaller tags with strong solubility enhancing
effects are desirable. Recently, the 8-kDa calcium binding protein
Fh8 from the parasite Fasciola hepatica was shown to be as good
as or better than the large tags in terms of solubility enhancement.
Moreover, the recombinant proteins maintained their solubility
after tag removal (Costa et al., 2013). MBP and GST can be used
to purify the fused protein by afﬁnity chromatography, as MBP
binds to amylose–agarose and GST to glutathione–agarose. MBP
is present in the pMAL series of vectors from NEB and GST
in the pGEX series (GE). A peptide tag must be added to the
fusion partner-containing protein if an afﬁnity chromatography
step is needed in the puriﬁcation scheme. MBP and GST bind to
their substrates non-covalently. On the contrary, the HaloTag7
(Promega) is based on the covalent capture of the tag to the
resin, making the system fast and highly speciﬁc (Ohana et al.,
2009).
A different group of fusion tags are stimulus-responsive tags,
which reversibly precipitate out of solution when subjected to
the proper stimulus. The addition of β roll tags to a recombi-
nant protein allows for its selective precipitation in the presence
of calcium. The ﬁnal products presented a high purity and
the precipitation protocol only takes a couple of minutes (Shur
et al., 2013). Another protein-based stimulus-responsive puriﬁ-
cation tags are elastin-like polypeptides (ELPs), which consist
of tandem repeats of the sequence VPGXG, where X is Val,
Ala, or Gly in a 5:2:3 ratio (Meyer and Chilkoti, 1999). These
tags undergo an inverse phase transition at a given temperature
of transition (T t). When the T t is reached, the ELP–protein
fusion selectively and reversibly precipitates, allowing for quick
enrichment of the recombinant protein by centrifugation (Banki
et al., 2005). Precipitation can also be triggered by adjusting the
ionic strength of the solution (Ge et al., 2005). These techniques
represent an alternative to conventional chromatography-based
puriﬁcation methods and can save production costs, especially
in large-scale settings (Fong and Wood, 2010). The main char-
acteristics of the tags mentioned in this section are outlined on
Table 1.
TAG REMOVAL
If structural or biochemical studies on the recombinant protein
are needed, then the fusion partner must be eliminated from the
recombinant protein. Peptide tags should be removed too because
they can interfere with protein activity and structure (Wu and
Filutowicz, 1999; Perron-Savard et al., 2005), but they can be left in
place even for crystallographic studies (Bucher et al., 2002; Carson
et al., 2007). Tags can be eliminated by either enzymatic cleavage
or chemical cleavage.
In the case of tag removal by enzyme digestion, expression
vectors possess sequences that encode for protease cleavage sites
downstream of the gene coding for the tag. Enterokinase, throm-
bin, factor Xa and the tobacco etch virus (TEV) protease have all
been successfully used for the removal of peptide tags and fusion
partners (Jenny et al., 2003; Blommel and Fox, 2007). Choosing
among the different proteases is based on speciﬁcity, cost, number
of amino acids left in the protein after cleavage and ease of removal
after digestion (Waugh, 2011). Enterokinase and thrombin were
popular in the past but the use of His-tagged TEV has become an
everyday choice due to its high speciﬁcity (Parks et al., 1994), it is
easy to produce in large quantities (Tropea et al., 2009) and leaves
only a serine or glycine residue (or even the natural N-terminus)
after digestion (Kapust et al., 2002).
As the name implies, in chemical cleavage the tag is removed
by treatment of the fusion protein with a chemical reagent. The
advantages of using chemicals for this purpose are that they are
easy to eliminate from the reaction mixture and are cheap in com-
parison with proteolytic enzymes, which makes them an attractive
choice in the large-scale production of recombinant proteins
(Rais-Beghdadi et al., 1998). However, the reaction conditions
are harsh, so their use is largely restricted to puriﬁed recombi-
nant proteins obtained from IBs. They also often cause unwanted
protein modiﬁcations (Hwang et al., 2014). The most common
chemical cleavage reagent is cyanogen bromide (CNBr). CNBr
cleaves the peptide bond C-terminal to methionine residues, so
this amino acid should be present between the tag and the protein
of interest (Rais-Beghdadi et al., 1998). Also, the target protein
should not contain internal methionines. CNBr cleavage can be
performed in common denaturing conditions (6 M guanidinium
chloride) or 70% formic acid or triﬂuoroacetic acid (Andreev et al.,
2010). Other chemical methods for protein cleavage can be found
in Hwang et al. (2014).
THIRD QUESTION: WHICH IS THE APPROPRIATE HOST?
A quick search in the literature for a suitable E. coli strain to use
as a host will yield dozens of possible candidates. All of them
have advantages and disadvantages. However, something to keep
in mind is that many are specialty strains that are used in speciﬁc
situations. For a ﬁrst expression screen, only a couple of E. coli
strains are necessary: BL21(DE3) and some derivatives of the K-12
lineage.
The history of the BL21 and BL21(DE3) strains was beautifully
documented in Daegelen et al. (2009) and we recommend this
article to the curious. BL21 was described by Studier in 1986 after
various modiﬁcations of the B line (Studier and Moffatt, 1986),
which in turn Daegelen et al. (2009) traced back to d’Herelle.
A couple of genetic characteristics of BL21 are worthy of men-
tion. Like other parental B strains, BL21 cells are deﬁcient in the
Lon protease, which degrades many foreign proteins (Gottesman,
1996). Another gene missing from the genome of the ancestors of
BL21 is the one coding for the outer membrane protease OmpT,
whose function is to degrade extracellular proteins. The liberated
amino acids are then taken up by the cell. This is problematic
in the expression of a recombinant protein as, after cell lysis,
OmpT may digest it (Grodberg and Dunn, 1988). In addition,
plasmid loss is prevented thanks to the hsdSB mutation already
present in the parental strain (B834) that gave rise to BL21. As a
result, DNA methylation and degradation is disrupted. When the
gene of interest is placed under a T7 promoter, then T7 RNAP
should be provided. In the popular BL21(DE3) strain, the λDE3
prophage was inserted in the chromosome of BL21 and contains
the T7 RNAP gene under the lacUV5 promoter, as was explained
earlier.
The BL21(DE3) and its derivatives are by far the most used
strains for protein expression. Still, there are reports where the
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Table 1 | Main characteristics of protein fusion tags.
Residues/Size (kDa) Ligand/Matrix Purification conditions
Peptide tags
Poly-Arg Usually 5/0.80 Cation-exchange resin NaCl linear gradient (0–400 mM)
Poly-His Usually 6/0.84 Ni2+-nitrilotriacetic acid-agarose 20–250 mM Imidazole/low pH
FLAG 8/1.01 Anti-FLAG antibody
immunodecorated agarose
2–5 mM EDTA
Strep-tag II 8/1.06 Specially engineered streptavidin
(Strep-Tactin)
2–25 mM desthiobiotin
c-myc 11/1.20 Anti-myc antibody
immunodecorated agarose
Low pH
S-tag 15/1.75 S-protein (RNase A, residues
21–124) agarose
3 M guanidinium thiocyanate; 0.2 M
potassium citrate buffer, pH 2 or
3 M MgCl2
Fusion partnersa Solubility enhancementb
Fh8 69/8.0 Ca2+-dependent binding to
phenyl-Sepharose
10 mM EDTA ND
Trx 109/11.7 4-amino phenylarsine oxide agarose
(alternatively an afﬁnity tag can be
added)
5–1000 mM b-βmercaptoethanol +++
SUMO ca. 100/12.0 An afﬁnity tag must be added
(usually His-tag)
++++
BRT17 (β roll tag) 153/14.7 Precipitation in the presence of
25–75 mM Ca2+
ND
GST 211/26.0 Glutathione–agarose 10–20 mM reduced glutathione +
HaloTag7 ca. 300/34.0 Chloroalkane ligand attached to
agarose
A protease cleavage site is added
between the tag and the protein for
in-column cleavage
ND
MBP 396/ca. 42.5 Cross-linked amylose 10 mM maltose +++
ELPs 550 (for 110 repeats)/ca.
47.0
Precipitation by temperature shifts
and/or high concentrations of NaCl
(>1.5 M)
ND
NusA 495/54.8 An afﬁnity tag must be added
(usually His-tag)
++
aNumber of residues and size of fusion partners are approximate in some cases, as many variants exist. bThe grading in the solubility enhancement column is based
on the results of Bird (Bird, 2011); ND, not determined in that study.
K-12 lineage is used for this purpose. The AD494 and OrigamiTM
(Novagen) strains are trxB (thioredoxin reductase) mutants, so
disulﬁde bond formation in the cytoplasm is enhanced (the
Origami strain also lacks the glutathione reductase gene; Der-
man et al., 1993). Another widely used strain from the K-12
repertoire is HMS174, a recA mutant (Campbell et al., 1978).
This mutation has a positive effect on plasmid stability (Marisch
et al., 2013). Plasmid multimer formation, an important cause of
instability, relies on the recombination system of E. coli (Sum-
mers et al., 1993). All three strains have their λDE3-containing
derivative (available at Novagen) so the T7 RNAP system can be
used.
FOURTH QUESTION: WHICH IS THE COMBINATION FOR
SUCCESS?
At this point, it should be pretty clear that the number of options
when designing an expression system is considerably high. Choos-
ing the perfect combination is not possible a priori, so multiple
conditions should be tested to obtain the desired protein. If the
project demands expressing two protein constructs, cloned in six
different expression vectors, each transformed in three different
expression strains, then you are in for 36 expression trials. This
number may be even higher when other variables are taken into
account. This trial-and-error and time consuming pilot study can
be made faster if micro-expression trials are performed before
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scale-up. Small-scale screens can be performed in 2-ml tubes
or 96-well plates (Shih et al., 2002). High throughput protocols
adapting automatic liquid handling robots have been described,
making it possible for a single person to testmore than1000 culture
conditions within a week.
TROUBLESHOOTING RECOMBINANT PROTEIN PRODUCTION
This section of the review covers different strategies for optimiz-
ing recombinant protein production in E. coli. Even after careful
selection of plasmid and host, it cannot be predicted if the pro-
tein will be obtained in high amounts and in a soluble active
form. Various situations that impede reaching that goal can be
encountered,which unfortunately happen very often. Many things
to try in each case are discussed in the following paragraphs
and, for convenience of the readers; a summary is included in
Table 2.
NO OR LOW PRODUCTION
This situation may be regarded as the worst case scenario. When
the protein of interest cannot be detected through a sensitive tech-
nique (e.g., Western blot) or it is detected but at very low levels
(less than micrograms per liter of culture), the problem often lies
in a harmful effect that the heterologous protein exerts on the cell
(Miroux and Walker, 1996; Dumon-Seignovert et al., 2004).
Protein toxicity
The problem of protein toxicity may arise when the recombinant
protein performs an unnecessary and detrimental function in the
host cell. This function interferes with the normal proliferation
and homeostasis of the microorganism and the visible result is
slower growth rate, low ﬁnal cell density, and death (Doherty et al.,
1993; Dong et al., 1995).
As a ﬁrst measure, cell growth should be monitored before
induction. If the growth rate of the recombinant strain is slower
compared to an empty-vector bearing strain then two causes may
explain the phenotype: gene toxicity and basal expression of the
toxic mRNA/protein. Gene toxicity will not be discussed here and
the review of Saida et al. (2006) is recommended.
The control of basal synthesis was covered in some detail in
Section “Promoter.” As stated, the expression of LacI from lacI
or lacIQ represses transcription of lac-based promoters. For high
copy number plasmids (>100 copies per cell), lacIQ should be
cloned in the expression vector. The pQE vectors from Qiagen
utilize two lac operator sequences to increase control of the T5
promoter, which is recognized by the E. coli RNA polymerase
(see The QIAexpressionistTM manual from Qiagen). A tighter
control can be achieved by the addition of 0.2–1% w/v glucose
in the medium as rich media prepared with tryptone or pep-
tone may contain the inducer lactose (Studier, 2005). Another
option could be to prepare deﬁned media using glucose as a source
of carbon. In T7-based promoters, leaky expression is avoided
by co-expression of T7 lysozyme from the pLysS or pLysE plas-
mids (see above). Use of lower copy number plasmids containing
tightly regulated promoters (like the araPBAD promoter) is sug-
gested. An interesting case of copy number control is the one
employed in pETcoco vectors (Novagen). These plasmids pos-
sess two origins of replication. The oriS origin and its control
elements maintain pETcoco at one copy per cell (Wild et al.,
2002). However, the TrfA replicator activates the medium-copy
origin of replication (oriV) and ampliﬁcation of copy num-
ber is achieved (up to 40 copies per cell). The trfA gene is on
the same vector and is under control of the araPBAD promoter,
so copy number can be controlled by arabinose (Wild et al.,
2002).
After control of basal expression, the culture should grow well
until the proper time of induction. At this moment, if the protein
is toxic, cell growth will be arrested. In many cases, the level of
toxicity of a protein becomes apparent when a certain threshold
of host tolerance is reached and exceeded. In such situations, the
level of expression should be manipulated at will. Tunable expres-
sion can be achieved using the Lemo21(DE3) strain. This strain
is similar to the BL21(DE3)pLysS strain, however, T7 lysozyme
production from the lysY gene is under the tunable promoter
rhaPBAD (Wagner et al., 2008). At higher concentrations of the
sugar L-rhamnose, more T7 lysozyme is produced, less active
T7 RNAP is present in the cell and less recombinant protein
is expressed. Trials using L-rhamnose concentrations from 0 to
2,000 μM should be undertaken to ﬁnd the best conditions for
expression. By contrast, dose-dependent expression when using
IPTG as inducer is not possible since IPTG can enter the cell
by active transport through the Lac permease or by permease-
independent pathways (Fernandez-Castane et al., 2012). Since
expression of Lac permease is heterogeneous and the number of
active permeases in each cell is highly variable, protein expression
does not respondpredictably to IPTGconcentration. TheTunerTM
(DE3) strain (Novagen) is a BL21 derivative that possesses a lac
permease (lacY ) mutation that allows uniform entry of IPTG into
all LacY− cells in the population, which produces a concentration-
dependent, homogeneous level of induction (Khlebnikov and
Keasling, 2002). In the same line of thought, an E. coli strain
was constructed by exchanging the wild-type operator by the
derivative lacOc , thus converting the lac operon into a consti-
tutive one. This modiﬁcation avoids the transient non-genetic
LacY− phenotype of a fraction of the cells, allowing uniform
entry of the inducer lactose. A second modiﬁcation (gal+) per-
mits the full utilization of lactose as an energy source (Menzella
et al., 2003).
Awordof cautionneeds tobe said in regard to“tunable promot-
ers” that are inducible by sugars (lactose, arabinose, rhamnose).
In the case of the araPBAD promoter, the yields of the target pro-
tein can be reproducibly increased over a greater than 100-fold
range by supplementing the culture with different sub-maximal
concentrations of arabinose (Guzman et al., 1995). This led to the
erroneous belief thatwithin each cell, the level of recombinant pro-
tein synthesis can be manipulated at will. However, it was shown
that the range in protein expression arises from the heterogeneity
in the amount of active sugar permeases in each cell, as was also
explained for LacY (Siegele and Hu, 1997). So, even though the
ﬁnal protein yield can be controlled, the amount of protein per
cell is widely variable, with cells producing massive amounts of
protein and others not producing any protein at all. This can be
a nuance, since in the case of toxic products; the subpopulation
of cells with high-level synthesis may perish (Doherty et al., 1993;
Dong et al., 1995).
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Table 2 | Strategies for overcoming common problems during recombinant protein expression in E. coli.
Problem Possible explanation Solutions
No or low expression Protein may be toxic before
induction
Control basal induction:
• add glucose when using expression vectors containing lac-based promoters
• use deﬁned media with glucose as source of carbon
• use pLysS/pLysE bearing strains in T7-based systems
• use promoters with tighter regulation
Lower plasmid copy number
Protein may be toxic after induction Control level of induction:
• Tuneable promoters
• Use strains that allow control of induction [Lemo21(DE3) strain] or
lacY − strains (TunerTM)
Lower plasmid copy number
Use strains that are better for the expression of toxic proteins (C41 or C43)
Direct protein to the periplasm
Codon bias Optimize codon frequency in cDNA to better reﬂect the codon usage of the host
Use codon bias-adjusted strains
Increase biomass:
• Try new media formulations
• Provide good aeration and avoid foaming
Inclusion body formation Incorrect disulﬁde bond formation Direct protein to the periplasm
Use E. coli strains with oxidative cytoplasmic environment
Incorrect folding Co-express molecular chaperones
Supplement media with chemical chaperones and cofactors
Remove inducer and add fresh media
Lower production rate:
• Lower temperature. If possible, use strains with cold-adapted chaperones
• Tune inducer concentration
Low solubility of the protein Fuse desired protein to a solubility enhancer (fusion partners)
An essential post translational
modiﬁcation is needed
Change microorganism
Protein inactivity Incomplete folding Lower temperature
Monitor disulﬁde bond formation and allow further folding in vitro
Mutations in cDNA Sequence plasmid before and after induction. If mutations are detected, the
protein may be toxic.
Use a recA− strain to ensure plasmid stability
Transform E. coli before each expression round
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Some E. coli mutants were speciﬁcally selected to withstand the
expression of toxic proteins. The strains C41(DE3) and C43(DE3)
were found by Miroux and Walker (1996) in a screen designed to
isolate derivatives of BL21(DE3) with improved membrane pro-
tein overproduction characteristics. It was recently discovered that
the previously uncharacterizedmutationswhich prevent cell death
during the expression of recombinant proteins in these strains lie
on the lacUV5 promoter. In BL21(DE3) cells, the lacUV5 pro-
moter drives the expression of the T7 RNAP, but in the Walker
strains two mutations in the −10 region revert the lacUV5 pro-
moter back into the weaker wild-type counterpart. This leads to a
lesser (and perhaps more tolerable for the cell) level of synthesis
(Wagner et al., 2008).
Another solution could be to remove the protein from the cell.
Secretion to the periplasm or to the medium is sometimes the only
way to produce a recombinant protein (Mergulhao et al., 2005;
de Marco, 2009). The ﬁrst option for expression in the periplasm
is the post-translational Sec-dependent pathway (Georgiou and
Segatori, 2005). Routing to the extracytoplasmatic space is
achieved by fusing the recombinant protein to a proper leader
peptide. The signal peptides of the following proteins are widely
used for secretion: Lpp, LamB, LTB, MalE, OmpA, OmpC, OmpF,
OmpT, PelB, PhoA, PhoE, or SpA (Choi and Lee, 2004). The co-
translational translocation machinery based on the SRP (signal
recognition particle) pathway can also be used. SRP recognizes
its substrates by the presence of a hydrophobic signal sequence
located in the N-terminal end. Following interaction with the
membrane receptor FtsY, the complex of nascent chain and ribo-
some is transferred to the SecYEG translocase (Valent et al., 1998).
The signal sequence of disulﬁde isomerase I (DsbA) has been used
to target recombinant proteins to the periplasm via the SRP path-
way. Notable examples of recombinant proteins secreted though
this system include thioredoxin (Schierle et al., 2003) and the
human growth hormone (Soares et al., 2003).
Codon bias
Codon bias arises when the frequency of occurrence of syn-
onymous codons in the foreign coding DNA is signiﬁcantly
different from that of the host. At the moment of full syn-
thesis of the recombinant protein, depletion of low-abundance
tRNAs occurs. This deﬁciency may lead to amino acid misin-
corporation and/or truncation of the polypeptide, thus affecting
the heterologous protein expression levels (which will be low
at best) and/or its activity (Gustafsson et al., 2004). To check
if codon bias could be an issue when expressing a recombi-
nant protein, a large number of free online apps detect the
presence of rare codons in a given gene when E. coli is used
as a host (molbiol.ru/eng/scripts/01_11.html, genscript.com/cgi-
bin/tools/rare_codon_analysis, nihserver.mbi.ucla.edu/RACC/,
just to name a few). Rare codons were deﬁned as codons used
by E. coli at a frequency <1% (Kane, 1995). For example, the
AGG codon (Arg) is used in E. coli at a frequency of <0.2%,
but it is not rare in plant mRNAs where it can reach frequencies
>1.5%.
Two strategies for solving codon usage bias have been used:
codon optimization of the foreign coding sequence or increasing
the availability of underrepresented tRNAs by host modiﬁcation
(Sorensen and Mortensen, 2005). The rationale behind codon
usage optimization is to modify the rare codons in the target
gene to mirror the codon usage of the host (Burgess-Brown et al.,
2008;Welch et al., 2009; Menzella, 2011). The amino acid sequence
of the encoded protein must not be altered in the process. This
can be done by site-directed silent mutagenesis or resynthesis
of the whole gene or parts of it. Codon optimization by silent
mutagenesis is a cumbersome and expensive process, so is not
very useful when many recombinant proteins are needed. On the
other hand, gene synthesis by design is not a trivial issue since it
requires choosing the best sequence from a vast number of possi-
ble combinations (Gustafsson et al., 2004). The simplest approach
is to replace all instances of a given amino acid in the target
gene by the most abundant codon of the host, a strategy called
“one amino acid-one codon.” More advanced algorithms, which
employ several other optimization parameters such as codon con-
text and codon harmonization, have been described (Gao et al.,
2004; Supek and Vlahovicek, 2004; Jayaraj et al., 2005; Angov
et al., 2011). Some are freely available as web servers or standalone
software. For a comprehensive list, please refer to Puigbo et al.
(2007).
Correcting codon usage is a tricky situation. The “one amino
acid-one codon”strategydisregards factors other than codon rarity
that inﬂuence protein expression levels. For example, in bacterial
genes enriched in rare codons at the N-terminus, protein expres-
sion is actually improved. The cause lies not in codon rarity per
se but in the reduction of RNA secondary structure (Goodman
et al., 2013). In addition, a recent report has shown that high lev-
els of protein production are mainly (but not only) determined
by the decoding speed of the open reading frame (i.e., the time
it takes for a ribosome to translate an mRNA), especially if “fast”
codons are located at the 5′-end of the mRNA (Chu et al., 2014).
This causes a fast ribosome clearance at the initiation site, so that
new recruited ribosomes encounter a free start codon and can
engage in translation. Finally, some codoncombinations can create
Shine–Dalgarno-like structures that cause translational pausing by
hybridization between the target mRNA and the 16S rRNA of the
translating ribosome (Li et al., 2012). Translational pausing along
the mRNA has a beneﬁcial effect in protein folding, as it allows for
the newly synthesized chain to adopt a well-folded intermediate
conformation (Thanaraj and Argos, 1996; Oresic and Shalloway,
1998; Tsai et al., 2008; Yona et al., 2013). All of this new evidence
in translational control mechanisms poses a challenge in the ratio-
nal design of synthetic genes. Newer algorithms should account
for 5′ RNA structure, presence of strategically located Shine–
Dalgarno-like motifs, ribosome clearance rates at the initiation
site and presence of slowly translated regions that are beneﬁcial in
co-translational folding.
On the other hand, when the cell is producingmassive amounts
of proteins (as in the case of recombinant expression of het-
erologous genes), charged tRNA availability for rare codons does
become the major determinant of the levels of produced protein
(Pedersen, 1984; Li et al., 2012). Low-abundance tRNA deple-
tion causes ribosome stalling and its subsequent detachment
from the RNA strand and thus, failure to generate a full-length
product (Buchan and Stansﬁeld, 2007). Several strains carrying
plasmids containing extra copies of problematic tRNAs genes can
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be used to circumvent this issue. The BL21(DE3)CodonPlus strain
(Stratagene) contains the pRIL plasmid (p15A replicon, which is
compatible with the ColE1 and ColE1-like origins contained in
most commonly used expression vectors), which provides extra
genes for the tRNAs for AGG/AGA (Arg), AUA (Ile), and CUA
(Leu). BL21(DE3)CodonPlus-RP (Stratagene) corrects for the use
of AGG/AGA (Arg) and CCC (Pro). The Rosetta(DE3) strains
(Novagen) areTunerTM derivatives containing the pRAREplasmid
(p15A replicon), supplying tRNAs for all the above-mentioned
codons plus GGA (Gly). It should be noted that the use of these
strains often improves the levels of protein production but some-
times can cause a decrease in protein solubility.We have found that
proteins with higher than 5% content of RIL codons (AGG/AGA,
AUA, and CUA) are less soluble when expressed in the Codon-
Plus strain. In this host, the translational pauses introduced by the
RIL codons are probably overridden, increasing translation speed
and consequently, protein aggregation (Rosano and Ceccarelli,
2009).
Limiting factors in batch cultivation
When the expression of the recombinant protein is low and can-
not be increased by the proposedmechanisms, then the volumetric
yield of desired protein can be augmented by growing the culture
to higher densities. This can be achieved by changing a few param-
eters, like medium composition and providing better aeration by
vigorous shaking (McDaniel and Bailey, 1969; Cui et al., 2006;
Blommel et al., 2007).
LB is the most commonly used medium for culturing E. coli.
It is easy to make, it has rich nutrient contents and its osmolarity
is optimal for growth at early log phase. All these features make
it adequate for protein production and compensate for the fact
that it is not the best option for achieving high cell density cul-
tures. Despite being a rich broth, cell growth stops at a relatively
low density. This happens because LB contains scarce amounts
of carbohydrates (and other utilizable carbon sources) and diva-
lent cations (Sezonov et al., 2007). Not surprisingly, increasing the
amount of peptone or yeast extract leads to higher cell densities
(Studier, 2005). Also, divalent cation supplementation (MgSO4 in
the millimolar range) results in higher cell growth. Adding glucose
is of limited help in this regard because acid generation by glucose
metabolism overwhelms the limited buffer capacity of LB, at least
in shake ﬂasks where pH control can be laborious (Weuster-Botz
et al., 2001; Scheidle et al., 2011). If culture acidiﬁcation poses a
problem, themedia can be bufferedwith phosphate salts at 50mM.
2xYT, TB (Terriﬁc Broth) and SB (Super Broth) media recipes are
available elsewhere and have been shown to be superior to LB for
reaching higher cell densities (Madurawe et al., 2000; Atlas, 2004;
Studier, 2005).
A major breakthrough in media composition came in 2005
by the extensive work of Studier. In that report, the concept of
autoinduction was developed (Studier, 2005). In autoinduction
media, a mixture of glucose, lactose, and glycerol is used in an
optimized blend. Glucose is the preferred carbon source and is
metabolized preferentially during growth, which prevents uptake
of lactose until glucose is depleted, usually in mid to late log
phase. Consumption of glycerol and lactose follows, the latter
being also the inducer of lac-controlled protein expression. In this
way, biomass monitoring for timely inducer addition is avoided,
as well as culture manipulation (Studier, 2014).
As the number of cells per liter increases, oxygen availability
becomes an important factor with profound inﬂuence on growth
(O’Beirne and Hamer, 2000; Losen et al., 2004).Oxygen limitation
triggers the expression of more than 200 genes in an attempt to
adjust the metabolic capacities of the cell to the availability of oxy-
gen, all of which hinder optimal growth over long culture periods
(Unden et al., 1995). The easiest way to increase the amount of
available oxygen in shake vessels is to increase shaking speed. For
regular ﬂasks, the optimal shaking speed range is 400–450 rpm.
More agitation is generated in bafﬂed ﬂasks; under these con-
ditions, 350–400 rpm are enough for good aeration. However,
vigorous shaking can induce the formation of foam, which will
lower oxygen transfer. For this reason, the addition of an antifoam-
ing agent is recommended, although it was shown that antifoams
can affect the growth rate of several microorganisms and the yield
of recombinant protein (Routledge et al., 2011; Routledge, 2012).
Also, proper aeration depends on the ratio of culture volume to
vessel capacity. As a rule of thumb, the culture volume should
be less or equal to 10% of the shaking ﬂask capacity, although
in our hands, protein production with culture volumes occupy-
ing 20% of the ﬂask capacity was possible (Rosano et al., 2011).
A strategy that can produce signiﬁcant increases in cell density is
fed-batch fermentation. This approach has a wide availability of
tools and methods, but it is beyond the scope of this paper and is
addressed elsewhere (Yamanè and Shimizu, 1984; Yee and Blanch,
1992; Moulton, 2013).
Two rarely discussed parameters in the process of recombinant
protein production are the preparation of the starting culture and
the time of induction. Most protocols call for diluting a satu-
rated overnight preculture (dilution factor 1/100) into the larger
culture (Sivashanmugam et al., 2009). However, leaky expression
of the chosen system can lead to plasmid instability, which may
result in a poor yield of target protein. Also, in the starter cul-
ture, cells can be in dissimilar metabolic states. Upon dilution into
fresh media, cells will grow at different rates leading to irrepro-
ducible induction points (Huber et al., 2009). A proper preculture
(cells in an active equalized growing phase) can be prepared by
growing the overnight starter culture at 20–25◦C or by using a
slow-release system for glucose, among other methods (Busso
et al., 2008; Huber et al., 2009; Sivashanmugam et al., 2009). After
inoculation and further growth, the inducer is often added in
mid-log phase because the culture is growing fast and protein
translation is maximal. However, induction at early stationary
phase is also possible (Ou et al., 2004). In fact, in some cases the
target protein was more soluble when inducer was added at this
stage (Galloway et al., 2003). Presumably, the reduced rate of pro-
tein synthesis may result in less aggregation in IBs, as we describe
below.
INCLUSION BODIES FORMATION
When a foreign gene is introduced in E. coli, spatio-temporal
control of its expression is lost. The newly synthesized recom-
binant polypeptide is expressed in the microenvironment of
E. coli, which may differ from that of the original source in
terms of pH, osmolarity, redox potential, cofactors, and folding
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mechanisms. Also, in high level expression, hydrophobic stretches
in the polypeptide are present at high concentrations and avail-
able for interaction with similar regions. All of these factors lead
to protein instability and aggregation (Hartley and Kane, 1988;
Carrio and Villaverde, 2002). These buildups of protein aggre-
gates are known as IBs. IB formation results from an unbalanced
equilibrium between protein aggregation and solubilization. So,
it is possible to obtain a soluble recombinant protein by strate-
gies that ameliorate the factors leading to IB formation (Carrio
and Villaverde, 2001, 2002). One is to fuse the desired pro-
tein to a fusion partner that acts as a solubility enhancer. Some
examples were already described in Section “Afﬁnity Tags.” In
some cases the generation of IB can be an advantage, espe-
cially if the protein can be refolded easily in vitro. If that is
the case, conditions can be adjusted to favor the formation IB,
providing a simple method for achieving a signiﬁcant one-step
puriﬁcation of the expressed protein (Burgess, 2009; Basu et al.,
2011).
Disulﬁde bond formation
For many recombinant proteins, the formation of correct disul-
ﬁde bonds is vital for attaining their biologically active three-
dimensional conformation. The formation of erroneous disulﬁde
bonds can lead to protein misfolding and aggregation into IB. In
E. coli, cysteine oxidation takes places in the periplasm, where
disulﬁde bonds are formed in disulﬁde exchange reactions cat-
alyzed by a myriad of enzymes, mainly from the Dsb family
(Messens and Collet, 2006). By contrast, disulﬁde bond forma-
tion in the cytoplasm is rare, maybe because cysteine residues are
part of catalytic sites in many enzymes. Disulﬁde bond forma-
tion at these sites may lead to protein inactivation, misfolding,
and aggregation (Derman et al., 1993). The cytoplasm has a more
negative redox potential and is maintained as a reducing envi-
ronment by the thioredoxin–thioredoxin reductase (trxB) system
and the glutaredoxin–glutaredoxin reductase (gor) system (Stew-
art et al., 1998). This situation has a huge impact in the production
of recombinant proteins with disulﬁde bonds. One option would
be to direct the protein to the periplasm, as we have discussed in
Section “Protein Toxicity.”
Nevertheless, expression in the cytoplasm is still possible
thanks to engineered E. coli strains that possess an oxidative
cytoplasmic environment that favors disulﬁde bond formation
(Derman et al., 1993). Worthy of mention are the Origami
(Novagen) and SHufﬂe (NEB) strains. We described earlier the
OrigamiTM strain, as having a trxB− gor− genotype in the
K-12 background (as this double mutant is not viable, a sup-
pressor mutation in the ahpC gene is necessary to maintain
viability; Bessette et al., 1999). OrigamiTM is also available in
the BL21(DE3) lacY (TunerTM, Novagen) background. Addi-
tion of the pRARE plasmid for the extra advantage of correcting
codon bias resulted in the construction of the Rosetta-gamiTM B
strain (Novagen). The SHufﬂe® T7 Express strain [BL21(DE3)
background, NEB] goes a little bit further. Besides the trxB−
and gor− mutations, it constitutively expresses a chromoso-
mal copy of the disulﬁde bond isomerase DsbC (Lobstein et al.,
2012). DsbC promotes the correction of mis-oxidized pro-
teins into their correct form and is also a chaperone that can
assist in the folding of proteins that do not require disulﬁde
bonds. Due to the action of DsbC, less target protein aggregates
into IB.
Chaperone co-expression/chemical chaperones and cofactor
supplementation
Molecular chaperones lie at the heart of protein quality control,
aiding nascent polypeptides to reach their ﬁnal structure (Hartl
and Hayer-Hartl, 2002). Other specialized types of chaperones,
like ClpB, can disassemble unfolded polypeptides present in IB.
The high level expression of recombinant proteins results in the
molecular crowding of the cytosol and quality control mecha-
nisms may be saturated in this situation (Carrio and Villaverde,
2002). One strategy for solving this problem is to stop pro-
tein expression by inducer removal after a centrifugation step
and addition of fresh media supplemented with chlorampheni-
col, an inhibitor of protein synthesis. This allows recruitment
of molecular chaperones to aid in the folding of newly syn-
thesized recombinant polypeptides (Carrio and Villaverde, 2001;
de Marco and De Marco, 2004).
Given their function, it is not surprising that efforts to inhibit
IB formation were directed to the co-expression of individual
or sets of molecular chaperones (Caspers et al., 1994; Nishi-
hara et al., 2000; de Marco et al., 2007). Commercially, one
of the most used systems is the chaperone plasmid set from
Takara (Nishihara et al., 1998, 2000). This set consists of ﬁve
plasmids (pACYC derivatives) which allow overexpression of dif-
ferent chaperones or combinations of them: (i) GroES-GroEL, (ii)
DnaK/DnaJ/GrpE, (iii) (i) + (ii), (iv) trigger factor, (v) (i) + (iv).
On the other hand, if such a system is not at hand, the natural
network of chaperones can be induced by the addition of ben-
zyl alcohol or heat shock, though the latter is not recommended
(de Marco et al., 2005).
When proteins are puriﬁed from IB, urea-denatured and then
refolded in vitro, addition of osmolytes (also called chemical chap-
erones) in the 0.1–1 M range of concentration increases the yield
of soluble protein (Rudolph and Lilie, 1996; Clark, 1998; Tsumoto
et al., 2003; Alibolandi and Mirzahoseini, 2011). This situation
can be mimicked in vivo by supplementing the culture media
with osmolytes such as proline, glycine-betaine, and trehalose (de
Marco et al., 2005). Also, the folding pathways that lead to the
correct ﬁnal conformation and stabilization of the proper folded
protein may require speciﬁc cofactors in the growth media, for
example, metal ions (such as iron-sulfur and magnesium) and
polypeptide cofactors. Addition of these compounds to the batch
culture considerably increases the yield as well as the folding rate
of soluble proteins (Sorensen and Mortensen, 2005).
Slowing down production rate
Slower rates of protein production give newly transcribed recom-
binant proteins time to fold properly. This was previously
addressed when we discussed the role of translational pauses at
rare codons and their impact in the production of recombinant
proteins. Moreover, the reduction of cellular protein concen-
tration favors proper folding. By far, the most commonly used
way to lower protein synthesis is reducing incubation tempera-
ture (Schein and Noteborn, 1988; Vasina and Baneyx, 1997; Vera
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et al., 2007). Low temperatures decrease aggregation, which is
favored at higher temperatures due to the temperature depen-
dence of hydrophobic interactions (Baldwin, 1986; Makhatadze
and Privalov, 1995; Schellman, 1997).
When IB formation is a problem, recombinant protein synthe-
sis should be carried out in the range 15–25◦C, though one report
described successful expression at 4◦C for 72 h (San-Miguel et al.,
2013). However, when working at the lower end of the tempera-
ture range, slower growth and reduced synthesis rates can result
in lower protein yields. Also, protein folding may be affected as
the chaperone network may not be as efﬁcient (McCarty and
Walker, 1991; Mendoza et al., 2000; Strocchi et al., 2006). The
ArticExpressTM (Stratagene) strain (B line) possesses the cold-
adapted chaperonin Cpn60 and co-chaperonin Cpn10 from the
psychrophilic bacterium Oleispira antarctica (Ferrer et al., 2004).
The chaperonins display high refolding activities at temperatures
of 4–12◦C and confer an enhanced ability for E. coli to grow at
lower temperatures (Ferrer et al., 2003).
PROTEIN INACTIVITY
Obtaining a nice amount of soluble protein is not the end of the
road. The protein may still be of bad quality; i.e., it does not have
the activity it should. Incomplete folding could be the culprit in
this scenario (Gonzalez-Montalban et al., 2007; Martinez-Alonso
et al., 2008). In this case, the protein adopts a stable soluble confor-
mation but the exact architecture of the active site is still unsuitable
for activity. Some options already addressed can be helpful in these
cases. Some proteins require small molecules or prosthetic groups
to acquire their ﬁnal folded conformation. Adding these com-
pounds to the culture media can increase the yield and the quality
of the expressed protein signiﬁcantly (Weickert et al., 1999; Yang
et al., 2003). Also, erroneous disulﬁde bond formation can lead to
protein inactivity (Kurokawa et al., 2000). In addition, protein pro-
duction at lower temperatures has a profound impact on protein
quality. Work by theVillaverde lab has shown that conformational
quality and functionality of highly soluble recombinant proteins
increase when the temperature of the culture is reduced (Vera
et al., 2007). This was also the case when the intracellular con-
centration of the chaperone DnaK was elevated (Martinez-Alonso
et al., 2007). This phenomenon calls into question the use of sol-
ubility as an indicator of quality. Based on this fact, then it may
be wise to express all recombinant proteins at low temperatures or
at least, to compare the speciﬁc activity of a recombinant protein
obtained at different temperatures.
If the activity of the heterologous protein is toxic to the cell,
genetic reorganization of the expression vector leading to loss of
activitymay occur, allowing the host to survive and eventually take
over the culture (Corchero and Villaverde, 1998). This structural
instability of the plasmid can be detected by DNA sequencing
after puriﬁcation of the plasmid at the end of process. Any point
mutation, deletion, insertion, or rearrangement may explain the
low activity of a puriﬁed recombinant protein (Palomares et al.,
2004).
CONCLUDING REMARKS
In terms of recombinant expression, E. coli has always been the
preferred microbial cell factory. E. coli is a suitable host for
expressing stably folded, globular proteins from prokaryotes and
eukaryotes. Even though membrane proteins and proteins with
molecular weights above 60 kDa are difﬁcult to express, several
reports have had success in this regard (our laboratory has pro-
duced proteins from plants in the 90–95 kDa range; Rosano et al.,
2011). Large-scale protein expression trials have shown that<50%
of bacterial proteins and <15% of non-bacterial proteins can be
expressed in E. coli in a soluble form, which demonstrates the ver-
satility of the system (Braun and LaBaer, 2003). However, when
coming across a difﬁcult-to-express protein, things can get compli-
cated. We hope to have given a thorough list of possible solutions
when facing the challenge of expressing a new protein in E. coli.
Nevertheless, a word of caution is needed. Many of the approaches
described in this review will fail miserably in a lot of cases. This
can be explained by the fact that strategies aiming at troubleshoot-
ing recombinant protein expression are sometimes protein speciﬁc
and suffer from positive bias; i.e., things that work get published,
all the others, do not. That being said, thanks to the efforts of
the scientiﬁc community, the general methods available in the lit-
erature are no longer anecdotal and can be used systematically.
Moreover, the ﬁeld is always expanding and even after almost 40
years from the ﬁrst human protein obtained in E. coli (Itakura
et al., 1977), there is still much room for improvement.
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